World Psychiatry 13 , 2835 (2014)
Our observation that tirzepatide use was associated with PDR but not with diabetic macular oedema is consistent with recent large post-marketing studies of GLP-1RA use [22]
The choice often comes down to accessibility, cost, and whether the treatment is being used for diabetes management, obesity, or both
Zepbound is FDA-approved for weight management and obstructive sleep apnea
That includes increasing demand for eggs, issues with a specific farm, and challenges across the supply chain
In the pediatric clinical trial, one SAXENDA-treated patient had an event of pancreatitis [see Warnings and Precautions (5.2)]